Effect of delamanid on interim outcomes of bacteriological conversion amongst pediatric drug resistant tuberculosis cases in India

Aim: To determine the bacteriological conversion rate after 6 months of Delamanid (DLM) based treatment in children with drug-resistant tuberculosis (DR-TB) and determine factors associated with bacteriological conversion. Methods: This is a descriptive retrospective study done in children between t...

Full description

Bibliographic Details
Published in:	Lung India
Main Authors:	Dhruv Kalawadia, Darshini Gandhi, Tsering Y Dirkhipa, Akanksha Jaiswal, Daksha Shah, Jyoti Salve, Malik Parmar, Kuldeep S Sachdeva, Minnie Bodhanwala, Ira Shah
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2024-01-01
Subjects:	children delamanid dlm dr-tb
Online Access:	http://www.lungindia.com/article.asp?issn=0970-2113;year=2024;volume=41;issue=1;spage=35;epage=39;aulast=Kalawadia

Similar Items

Pediatric Drug-Resistant Tuberculosis: The Current and Future Prospects for Management and Prevention
by: Dhanya Dharmapalan, et al.
Published: (2023-11-01)

Drug resistance to delamanid was detected in susceptible tuberculosis patient in Russia
by: Platon Eliseev, et al.
Published: (2024-12-01)

Treatment outcomes of bedaquiline-based longer oral antitubercular regimens in Indian children above five years of age
by: Ira Shah, et al.
Published: (2025-07-01)

Distribution of Minimum Inhibitory Concentrations and Resistance-associated Gene Mutations in Multidrug-resistant Mycobacterium tuberculosis Strains from Southern Türkiye: Insights on Bedaquiline, Delamanid, and Linezolid
by: Huda Ahmed, et al.
Published: (2024-12-01)

Rezultatele tratamentului tuberculozei multidrogrezistente cu utilizarea bedaquiline şi delamanid
by: Rafig Bayramov, et al.
Published: (2021-05-01)

Experience of Using Delamanid in the Treatment of Multiple Drug Resistant Tuberculosis
by: T. R. Bagdasaryan, et al.
Published: (2024-10-01)

Delamanid: Safety and Efficacy Analysis
by: G. N. Mozhokina, et al.
Published: (2023-12-01)

Mechanism of Action, Resistance, Synergism, and Clinical Implications of Delamanid Against Multidrug-Resistant Mycobacterium tuberculosis
by: Saeed Khoshnood, et al.
Published: (2021-10-01)

Effectiveness and safety of regimen containing bedaquiline and delamanid in patients with drug-resistant tuberculosis
by: Oki Nugraha Putra, et al.
Published: (2024-04-01)

Comparative safety of bedaquiline and delamanid in patients with multidrug resistant tuberculosis: A nationwide retrospective cohort study
by: Ju Hwan Kim, et al.
Published: (2023-08-01)

Delamanid is a new anti-tuberculosis drug: use, limitations, and prospects
by: V. N. Zimina, et al.
Published: (2021-03-01)

Drug resistance of Mycobacterium tuberculosis to linezolid and delamanid: a case report from Bukavu, Democratic Republic of Congo
by: Bertin C. Bisimwa, et al.
Published: (2025-07-01)

Bedaquiline, Delamanid, Linezolid, Clofazimine, and Capreomycin MIC Distributions for Drug Resistance Mycobacterium tuberculosis in Shanghai, China
by: Guo Y, et al.
Published: (2023-12-01)

Favorable outcome of individual regimens containing bedaquiline and delamanid in drug-resistant tuberculosis: A systematic review
by: Oki Nugraha Putra, et al.
Published: (2023-01-01)

Scoping review: QT interval prolongation in regimen containing bedaquiline and delamanid in patients with drug-resistant tuberculosis
by: Oki Nugraha Putra, et al.
Published: (2022-01-01)

Delamanid and bedaquiline resistance patterns in Mycobacterium tuberculosis in Iran: A cross-sectional analysis
by: AmirHossein Akbari Aghababa, et al.
Published: (2024-08-01)

Early experience of delamanid in extensively drug-resistant pulmonary tuberculosis
by: Vikas Marwah, et al.
Published: (2023-01-01)

New drugs in the treatment of drug-resistant tuberculosis in children. Experience with the use of delamanid in combination with bedaquiline
by: Ekaterina Sokolskaya, et al.
Published: (2024-12-01)

Specific Parameters of Toxic Reactions in Rats to the Combination of Delamanid and Drugs for Treatment of Drug Resistant Tuberculosis (A Pilot Study)
by: G. N. Mozhokina, et al.
Published: (2023-04-01)

Clinical outcomes of multidrug-resistant tracheobronchial tuberculosis receiving anti-tuberculosis regimens containing bedaquiline or delamanid
by: Qing Chen, et al.
Published: (2024-07-01)

Perspectives of targeted chemotherapy with delamanid in the treatment regimens of those with multiple/extensive drug resistant tuberculosis. A success, chance or uncertainty?
by: Aleksey G. Naumov, et al.
Published: (2018-11-01)

Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TB
by: James Millard, et al.
Published: (2023-05-01)

Investigation of delamanid, bedaquiline, and linezolid resistance rates and related gene mutations in multidrug-resistant Mycobacterium tuberculosis in regional tuberculosis reference laboratories of Iran
by: Nazanin Ahmad Khosravi, et al.
Published: (2025-08-01)

CRISPR Screening and Comparative LC‐MS Analysis Identify Genes Mediating Efficacy of Delamanid and Pretomanid against Mycobacterium tuberculosis
by: Mei‐Yi Yan, et al.
Published: (2024-10-01)

Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Children: The Role of Bedaquiline and Delamanid
by: Francesco Pecora, et al.
Published: (2021-05-01)

The effectiveness and safety of complex treatment of patients with drug-resistant pulmonary tuberculosis using delamanide
by: A. M. Tikhonov, et al.
Published: (2025-05-01)

Delamanid in the Treatment of MDR/pre-XDR TB in Arkhangelsk Region in 2019–2021
by: E. S. Khimova, et al.
Published: (2023-07-01)

Evaluation of the effectiveness of bedaquiline and delamanid treatment among children and adolescents with multi-drug-resistant pulmonary tuberculosis
by: M.I. Sakhelashvili, et al.
Published: (2023-03-01)

Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort
by: S. Koirala, et al.
Published: (2021-09-01)

Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort
by: S. Koirala, et al.
Published: (2021-09-01)

Comparison of Individual Regimen Containing Bedaquiline with Delamanid and Bedaquiline without Delamanid on Efficacy and Safety in Multidrug-resistant Tuberculosis Patients: Implementation in Dr. Soetomo General Academic Hospital, Indonesia
by: Soedarsono Soedarsono, et al.
Published: (2024-06-01)

Quabodepistat in combination with delamanid and bedaquiline in participants with drug-susceptible pulmonary tuberculosis: protocol for a multicenter, phase 2b/c, open-label, randomized, dose-finding trial to evaluate safety and efficacy
by: Rodney Dawson, et al.
Published: (2024-01-01)

Delamanid-containing regimens over 24 weeks for the treatment of multidrug-resistant/rifampicin-resistant tuberculosis: preliminary results from a single center in a multicenter, prospective, observational study
by: Fuping Yang, et al.
Published: (2025-09-01)

Evaluation of health-related quality of life and adherence among pre-extensively drug-resistant tuberculosis patients receiving either Bedaquiline or Delamanid regimen at a teaching hospital in Eastern India
by: Elisha Paikray, et al.
Published: (2024-10-01)

On the Definition and Location of the Aeroelastic Typical Section in Swept Wings
by: Miguel Nieto Gómez, et al.
Published: (2025-08-01)

Anti-Screenshot Watermarking Algorithm for Archival Image Based on Deep Learning Model
by: Wei Gu, et al.
Published: (2023-02-01)

Mitigating treatment failure of pulmonary pre-extensively drug-resistant tuberculosis: The role of new and repurposed drugs
by: Yi-Wen Huang, et al.
Published: (2024-08-01)

Static Aeroelastic Beam Model Development for Folding Winglet Design
by: Bereket Sitotaw Kidane, et al.
Published: (2020-07-01)

Compositional Spatio-Temporal PM<sub>2.5</sub> Modelling in Wildfires
by: Joseph Sánchez-Balseca, et al.
Published: (2021-10-01)

Sustained treatment success at 12 months for drug-resistant TB patients on concomitant bedaquiline-delamanid
by: V. Chavan, et al.
Published: (2025-02-01)